News

AddToAny

Google+ Facebook Twitter Twitter

"Don't delay cancer treatment"

A European Society for Medical Oncology (ESMO) interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published.

It encourages medical oncologists worldwide not to discontinue or delay any type of anti-cancer treatment that may potentially impact on overall survival. The experts also urge an end to labelling all cancer patients as vulnerable to coronavirus infection, since this may lead to inappropriate care and potential negative outcomes.

Earlier this year, ESMO developed guidelines for prioritising the various aspects of cancer care across different tumour types, with the aim to mitigate the negative effects of the pandemic on the management of cancer patients.  

bit.ly/2EC1oH3


Picture Credit | iStock

Related Articles

Histopathology qualification funding

The IBMS has announced new funding support for Institute members undertaking IBMS/RCPath histopathology qualifications.

IBMS podcast relaunched

The IBMS Biopod has been revamped, renamed and relaunched as IBMSpod.

Reporting in histopathology: some personal insights

The team at Leicester Royal Infirmary have collaborated on this article, which discusses their experiences of scientist reporting in histopathology.

"AI research could pose risk for patients"

Many studies claiming that artificial intelligence (AI) is as good as, or better than, human experts at interpreting medical images are of poor quality and potentially exaggerated.

Top